LMD-009 |
C-C Chemokine Receptor Type 8 (CCR8) Ligands |
CCR8-CCL1 |
Pharmacological Tools |
Biological Testing |
NOT DETERMINED |
Takeda Oncology (Originator) |
LMD-A |
C-C Chemokine Receptor Type 8 (CCR8) Ligands |
CCR8-CCL1 |
Antiallergy/Antiasthmatic Drugs |
Biological Testing |
Asthma |
Takeda Oncology (Originator) |
BMS-986340 |
Anti-CCR8 (C-C Chemokine Receptor Type 8) |
CCR8-CCL1 |
Oncolytic Drugs |
Preclinical |
Cancer |
Bristol-Myers Squibb (Originator) |
JTX-1811 |
Anti-CCR8 (C-C Chemokine Receptor Type 8) |
CCR8-CCL1 |
Oncolytic Drugs |
Preclinical |
Cancer |
Gilead Jounce Therapeutics (Originator) |
SRF-114 |
Anti-CCR8 (C-C Chemokine Receptor Type 8) |
CCR8-CCL1 |
Oncolytic Drugs |
Preclinical |
Cancer |
Surface Oncology Vaccinex (Originator) |
HBM-1022 |
Anti-CCR8 (C-C Chemokine Receptor Type 8) |
CCR8-CCL1 |
Oncolytic Drugs |
Preclinical |
Cancer |
Harbour BioMed (Originator) |
FPA-157 |
Anti-CCR8 (C-C Chemokine Receptor Type 8) |
CCR8-CCL1 |
Solid Tumors Therapy |
Preclinical |
Cancer, solid tumor |
Amgen (Originator) |